← Back to FR Documents
Notice

Determination That QMIIZ (Meloxicam) Orally Disintegrating Tablets, 7.5 Milligrams and 15 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

Document Details

Document Number2024-02710
TypeNotice
PublishedFeb 9, 2024
Effective Date-
RIN-
Docket IDDocket No. FDA-2023-P-4279
Text FetchedNo

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

Full Text

Text Not Yet Fetched

The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.